Polish pharmaceutical group Polpharma, which has recently acquired the Romanian drug manufacturer Biofarm in a deal valued at about EUR257 million, says that Romania is one of its strategic markets for growth in Central and Eastern Europe and announces it will continue to invest in the Romanian company’s development.
Romania is approaching a decisive period for its economic credibility as key international assessments converge, prompting the American Chamber of Commerce in Romania (AmCham Romania) to call for faster implementation of structural reforms and stronger political commitment to the country’s economic agenda.
The number of Romanian companies and authorized private individuals that filed for insolvency proceedings in the first five months of 2022 rose by 13.6% on the year to 3,146, according to the Romanian Trade Register Office (ONRC).
The number of insolvent Romanian companies and self-employed individuals rose by 13.6% on the year to 3,146 in January-May 2026, according to the Romanian Trade Registry Office (ONRC).